"Lived Experience, Representations & Psychic Processes in Patients

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The kidney transplant remains the privileged treatment of the terminal renal insufficiency. This care is complex for the patient both on a medical surgical plan and by the psychic reorganizations. Among the temporary contraindications of transplantation, us retrouvonsdes psychological reasons. The research work consists in highlighting the psychic mechanisms of the subjects awaiting kidney transplant.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05913596` - The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation	N/A

NCT number	NCT02690272
Study type	Interventional
Source	University Hospital, Angers
Contact
Status	Completed
Phase	N/A
Start date	February 29, 2016
Completion date	September 11, 2017

"Lived Experience, Representations and Psychic Processes in Patients Awaiting Kidney Transplantation" — LER-Psy-PAKT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms